Bioventus (BVS) Shares Outstanding (Diluted) (2021 - 2026)
Bioventus (BVS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Bioventus | 967.14 Mn | 937.68 Mn | 105.67 Mn | 70.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 70.84 Mn |
| Mar 28, 2026 | 70.01 Mn |
| Dec 31, 2025 | 68.91 Mn |
| Sep 27, 2025 | 68.84 Mn |
| Jun 28, 2025 | 68.54 Mn |
| Mar 29, 2025 | 66.01 Mn |
| Dec 31, 2024 | 64.55 Mn |
| Sep 28, 2024 | 65.26 Mn |
| Jun 29, 2024 | 64.06 Mn |
| Mar 30, 2024 | 63.38 Mn |
| Dec 31, 2023 | 62.65 Mn |
| Sep 30, 2023 | 62.82 Mn |
| Jul 1, 2023 | 62.55 Mn |
| Apr 1, 2023 | 62.12 Mn |
| Dec 31, 2022 | 61.39 Mn |
| Oct 1, 2022 | 61.67 Mn |
| Jul 2, 2022 | 61.48 Mn |
| Apr 2, 2022 | 60.48 Mn |
| Dec 31, 2021 | 45.47 Mn |
| Oct 2, 2021 | 41.84 Mn |